Published in PLoS One on January 24, 2013
The role of oxidative stress in menopause. J Midlife Health (2013) 0.98
miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα. PLoS One (2016) 0.77
The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action. Oncogene (2016) 0.75
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα. J Clin Invest (2017) 0.75
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn (2002) 4.01
From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev (2010) 3.11
Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev (2008) 3.05
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res (2009) 2.41
Building bone to reverse osteoporosis and repair fractures. J Clin Invest (2008) 2.40
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A (1999) 2.04
ERRalpha: a metabolic function for the oldest orphan. Trends Endocrinol Metab (2008) 1.83
PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab (2010) 1.77
What old means to bone. Trends Endocrinol Metab (2010) 1.64
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc Natl Acad Sci U S A (2004) 1.60
Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem (2006) 1.39
The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell (2011) 1.37
Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update (2005) 1.34
Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ (1998) 1.30
Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol (2011) 1.30
Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem (2009) 1.29
Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Mol Endocrinol (1999) 1.28
Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J Biol Chem (2007) 1.19
The NR3B subgroup: an ovERRview. Nucl Recept Signal (2007) 1.16
The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol (2001) 1.12
Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol (2009) 1.02
Estrogen-related receptor alpha modulates the expression of adipogenesis-related genes during adipocyte differentiation. Biochem Biophys Res Commun (2007) 1.01
Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res (2011) 1.00
Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos Int (2009) 0.98
Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells. PLoS One (2009) 0.95
ERRs and cancers: effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol (2011) 0.93
Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density. Endocrinology (2009) 0.90
The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J Biol Chem (2009) 0.88
Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency. PLoS One (2009) 0.87
ERR receptors as potential targets in osteoporosis. Trends Endocrinol Metab (2010) 0.87
Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling. J Mol Endocrinol (2012) 0.86
A novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha). Biochem Pharmacol (2010) 0.84
The Year in Basic Science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk. Mol Endocrinol (2008) 0.82
Estrogens repress PGC1-α expression in the uterus. Mol Cell Endocrinol (2010) 0.80
The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm Genome (2012) 2.65
Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant (2003) 2.42
Mouse large-scale phenotyping initiatives: overview of the European Mouse Disease Clinic (EUMODIC) and of the Wellcome Trust Sanger Institute Mouse Genetics Project. Mamm Genome (2012) 2.12
Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol (2004) 2.10
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol (2013) 2.04
Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J (2002) 1.64
Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice. Blood (2010) 1.64
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes. Blood (2012) 1.59
Genetic background determines metabolic phenotypes in the mouse. Mamm Genome (2008) 1.51
Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis? J Rheumatol (2013) 1.50
The cell cycle regulator CDC25A is a target for JAK2V617F oncogene. Blood (2011) 1.47
Chondrocytes play a major role in the stimulation of bone growth by thyroid hormone. Endocrinology (2014) 1.41
ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo. Gene (2013) 1.38
Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene. Mol Endocrinol (2002) 1.36
Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol (2007) 1.33
Osteoporosis in chronic kidney disease. Am J Kidney Dis (2004) 1.29
Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem (2009) 1.29
Receptor-interacting protein 140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes. Mol Endocrinol (2006) 1.27
JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα. Blood (2013) 1.25
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J (2008) 1.23
Sodium thiosulphate treatment of uraemic tumoral calcinosis. Rheumatology (Oxford) (2013) 1.21
Potentiation of ICI182,780 (Fulvestrant)-induced estrogen receptor-alpha degradation by the estrogen receptor-related receptor-alpha inverse agonist XCT790. J Biol Chem (2007) 1.19
AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem (2008) 1.19
A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation. PLoS Biol (2010) 1.14
Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet (2005) 1.13
Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep (2003) 1.12
Severe osteopenia in CFTR-null mice. Bone (2004) 1.11
Drilled hole defects in mouse femur as models of intramembranous cortical and cancellous bone regeneration. Calcif Tissue Int (2009) 1.10
Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. Am J Pathol (2008) 1.09
Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines. Blood (2009) 1.05
Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling. Ann Rheum Dis (2010) 1.05
Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med (2009) 1.03
In vivo discrimination of hip fracture with quantitative computed tomography: results from the prospective European Femur Fracture Study (EFFECT). J Bone Miner Res (2011) 1.01
Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo. Am J Pathol (2007) 1.01
Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem (2010) 1.00
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct (2014) 1.00
Expression of estrogen-receptor related receptors in amphioxus and zebrafish: implications for the evolution of posterior brain segmentation at the invertebrate-to-vertebrate transition. Evol Dev (2005) 1.00
Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine (2004) 0.98
The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells. Oncogene (2005) 0.98
Thyroid hormone activates fibroblast growth factor receptor-1 in bone. Mol Endocrinol (2003) 0.97
Early variations of host thyroxine and interleukin-7 favor Schistosoma mansoni development. J Parasitol (2002) 0.97
Crosstalk between cartilage and bone: when bone cytokines matter. Cytokine Growth Factor Rev (2011) 0.96
Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action. Am J Physiol Endocrinol Metab (2002) 0.96
Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology (2005) 0.96
Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab (2002) 0.95
Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice. Arthritis Rheumatol (2014) 0.95
Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone (2009) 0.93
ERRs and cancers: effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol (2011) 0.93
Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner. J Biol Chem (2010) 0.93
Murine Frizzled-1 behaves as an antagonist of the canonical Wnt/beta-catenin signaling. J Biol Chem (2003) 0.92
Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone. Mol Cell Endocrinol (2003) 0.92
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One (2013) 0.91
Absence of TI-VAMP/Vamp7 leads to increased anxiety in mice. J Neurosci (2012) 0.91
The orphan receptor ERRalpha interferes with steroid signaling. Nucleic Acids Res (2008) 0.90
Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol (2004) 0.90
Genome-wide linkage screen of bone mineral density (BMD) in European pedigrees ascertained through a male relative with low BMD values: evidence for quantitative trait loci on 17q21-23, 11q12-13, 13q12-14, and 22q11. J Clin Endocrinol Metab (2008) 0.89
Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-alpha or -beta: an echocardiograph study. Am J Physiol Endocrinol Metab (2002) 0.89
ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. J Pathol (2014) 0.89
The ERRalpha orphan nuclear receptor controls morphogenetic movements during zebrafish gastrulation. Dev Biol (2005) 0.89
A functionally conserved member of the FTZ-F1 nuclear receptor family from Schistosoma mansoni. Eur J Biochem (2002) 0.89
Bivariate association analysis in selected samples: application to a GWAS of two bone mineral density phenotypes in males with high or low BMD. Eur J Hum Genet (2011) 0.89
Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor alpha. Behav Brain Res (2006) 0.88
Studying non-mammalian models? Not a fool's ERRand! Trends Endocrinol Metab (2006) 0.88
Oestrogen deficiency modulates particle-induced osteolysis. Arthritis Res Ther (2011) 0.88
Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass. J Bone Miner Res (2011) 0.87
Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling. Aging Cell (2012) 0.87
Subchondral bone and osteoarthritis. Curr Opin Rheumatol (2015) 0.87
Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency. PLoS One (2009) 0.87
ERR receptors as potential targets in osteoporosis. Trends Endocrinol Metab (2010) 0.87
Etr-r3/mNapor, encoding an ELAV-type RNA binding protein, is expressed in differentiating cells in the developing rodent forebrain. Mech Dev (2002) 0.86
High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells. Cancer Res (2010) 0.86
Is lecturing in Rheumatology Satellite Symposia a male attribute? Rheumatol Int (2013) 0.86
Cloning and developmental expression of five estrogen-receptor related genes in the zebrafish. Dev Genes Evol (2004) 0.86
Thyroid hormone receptor {alpha} modulates lipopolysaccharide-induced changes in peripheral thyroid hormone metabolism. Endocrinology (2010) 0.86
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation. Am J Pathol (2012) 0.85
The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b. Bone (2012) 0.85
An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth. Hum Mol Genet (2012) 0.85
Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus. J Biol Chem (2006) 0.85
Role of the epigenetic regulator HP1γ in the control of embryonic stem cell properties. PLoS One (2010) 0.85
Assessment of dynamic humeral centering in shoulder pain with impingement syndrome: a randomised clinical trial. Ann Rheum Dis (2011) 0.85
Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency. J Cell Biochem (2008) 0.84
Adrenomedullin increases fibroblast-like synoviocyte adhesion to extracellular matrix proteins by upregulating integrin activation. Arthritis Res Ther (2010) 0.84
The endogenous retrovirus ENS-1 provides active binding sites for transcription factors in embryonic stem cells that specify extra embryonic tissue. Retrovirology (2012) 0.84
Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary. Mol Endocrinol (2003) 0.84
Layer-by-layer tissue microfabrication supports cell proliferation in vitro and in vivo. Tissue Eng Part C Methods (2011) 0.83
Adrenomedullin(22-52) combats inflammation and prevents systemic bone loss in murine collagen-induced arthritis. Arthritis Rheum (2011) 0.83
A case-control study of fractures in men with idiopathic osteoporosis: fractures are associated with older age and low cortical bone density. Bone (2012) 0.83
Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation. J Bone Miner Res (2012) 0.83
Chondrocalcinosis of femoro-tibial and proximal tibio-fibular joints in cadaveric specimens: a high-resolution CT imaging study of the calcification distribution. PLoS One (2013) 0.83
Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis. Bone (2008) 0.82